Orchid Pharma Limited (ORCHPHARMA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs115.10 Million ≈ $1.24 Million USD) by net assets (Rs12.74 Billion ≈ $137.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Orchid Pharma Limited's balance sheet to measure how much of total assets are equity-financed.
Orchid Pharma Limited - Cash Flow Conversion Efficiency Trend (2004–2026)
This chart illustrates how Orchid Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Orchid Pharma Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Orchid Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Orchid Pharma Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SFA Semicon Co. Ltd
KQ:036540
|
-0.016x |
|
Invesco Municipal Trust
NYSE:VKQ
|
0.022x |
|
Ipek Dogal Enerji Kaynaklari Arastirma ve Uretim AS
IS:IPEKE
|
-0.012x |
|
Electronics Mart India Limited
NSE:EMIL
|
0.167x |
|
Ningbo Sinyuan ZM Technology Co. Ltd. A
SHE:301398
|
N/A |
|
Sharda Motor Industries Limited
NSE:SHARDAMOTR
|
0.127x |
|
Jiangsu Tongli Risheng Machinery Co. Ltd.
SHG:605286
|
-0.068x |
|
PIERER Mobility AG
VI:PKTM
|
0.049x |
Annual Cash Flow Conversion Efficiency for Orchid Pharma Limited (2004–2026)
The table below shows the annual cash flow conversion efficiency of Orchid Pharma Limited from 2004 to 2026. For the full company profile with market capitalisation and key ratios, see how much is Orchid Pharma Limited worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs12.88 Billion ≈ $139.27 Million |
Rs1.10 Billion ≈ $11.88 Million |
0.085x | +462.76% |
| 2025-03-31 | Rs12.67 Billion ≈ $137.05 Million |
Rs192.15 Million ≈ $2.08 Million |
0.015x | -85.93% |
| 2024-03-31 | Rs11.69 Billion ≈ $126.47 Million |
Rs1.26 Billion ≈ $13.63 Million |
0.108x | +304.58% |
| 2023-03-31 | Rs6.89 Billion ≈ $74.47 Million |
Rs183.38 Million ≈ $1.98 Million |
0.027x | -81.36% |
| 2022-03-31 | Rs6.47 Billion ≈ $70.01 Million |
Rs924.75 Million ≈ $10.00 Million |
0.143x | +295.42% |
| 2021-03-31 | Rs6.53 Billion ≈ $70.61 Million |
Rs235.86 Million ≈ $2.55 Million |
0.036x | -65.76% |
| 2020-03-31 | Rs7.66 Billion ≈ $82.84 Million |
Rs808.03 Million ≈ $8.74 Million |
0.105x | +717.65% |
| 2019-03-31 | Rs-7.04 Billion ≈ $-76.14 Million |
Rs120.24 Million ≈ $1.30 Million |
-0.017x | -47.30% |
| 2018-03-31 | Rs-7.92 Billion ≈ $-85.63 Million |
Rs91.81 Million ≈ $992.84K |
-0.012x | +98.65% |
| 2017-03-31 | Rs-4.67 Billion ≈ $-50.48 Million |
Rs4.01 Billion ≈ $43.36 Million |
-0.859x | -119.85% |
| 2016-03-31 | Rs490.45 Million ≈ $5.30 Million |
Rs2.12 Billion ≈ $22.95 Million |
4.327x | +679.20% |
| 2015-03-31 | Rs3.29 Billion ≈ $35.62 Million |
Rs-2.46 Billion ≈ $-26.61 Million |
-0.747x | -353.59% |
| 2013-03-31 | Rs3.81 Billion ≈ $41.16 Million |
Rs1.12 Billion ≈ $12.12 Million |
0.295x | -52.70% |
| 2012-03-31 | Rs11.83 Billion ≈ $127.98 Million |
Rs7.37 Billion ≈ $79.71 Million |
0.623x | +100.87% |
| 2011-03-31 | Rs10.71 Billion ≈ $115.84 Million |
Rs3.32 Billion ≈ $35.92 Million |
0.310x | +947.20% |
| 2010-03-31 | Rs9.38 Billion ≈ $101.40 Million |
Rs-343.17 Million ≈ $-3.71 Million |
-0.037x | -150.53% |
| 2009-03-31 | Rs6.34 Billion ≈ $68.54 Million |
Rs459.01 Million ≈ $4.96 Million |
0.072x | -77.10% |
| 2008-03-31 | Rs6.65 Billion ≈ $71.92 Million |
Rs2.10 Billion ≈ $22.74 Million |
0.316x | +63.88% |
| 2007-03-31 | Rs4.85 Billion ≈ $52.46 Million |
Rs936.11 Million ≈ $10.12 Million |
0.193x | +1627.98% |
| 2006-03-31 | Rs7.76 Billion ≈ $83.88 Million |
Rs-97.95 Million ≈ $-1.06 Million |
-0.013x | -106.68% |
| 2005-03-31 | Rs4.61 Billion ≈ $49.83 Million |
Rs870.92 Million ≈ $9.42 Million |
0.189x | +667.99% |
| 2004-03-31 | Rs4.10 Billion ≈ $44.38 Million |
Rs-136.54 Million ≈ $-1.48 Million |
-0.033x | -- |
About Orchid Pharma Limited
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, m… Read more